These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
33. Review of pharmacotherapy options for the treatment of attention-deficit/hyperactivity disorder (ADHD) and ADHD-like symptoms in children and adolescents with developmental disorders. Rowles BM, Findling RL. Dev Disabil Res Rev; 2010; 16(3):273-82. PubMed ID: 20981766 [Abstract] [Full Text] [Related]
34. Clonidine for treatment of attention-deficit/hyperactivity disorder. Med Lett Drugs Ther; 1996 Dec 06; 38(989):109-10. PubMed ID: 8957471 [No Abstract] [Full Text] [Related]
35. An open-label, prospective study of guanfacine in children with ADHD and tic disorders. Boon-yasidhi V, Kim YS, Scahill L. J Med Assoc Thai; 2005 Nov 06; 88 Suppl 8():S156-62. PubMed ID: 16856436 [Abstract] [Full Text] [Related]
39. Association between Early Guanfacine Discontinuation and Somnolence for Attention-Deficit/Hyperactivity Disorder. Doi K, Sogawa R, Eguchi Y, Matsuo M, Shimanoe C. Biol Pharm Bull; 2024 Aug 06; 47(6):1204-1208. PubMed ID: 38910124 [Abstract] [Full Text] [Related]
40. Conflicting information from TGA versus FDA may undermine compliance with use of medication. Beckmann KM. Med J Aust; 2013 Jul 08; 199(1):28-9. PubMed ID: 23829255 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]